Regeneron Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Astellas Pharma JPY 187.84B 16.46B 2025-03
AstraZeneca 22.54B 79M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
J&J USD 9.54B 766M 2025-03
Kyowa Hakko Kirin JPY 98.38B 22.68B 2025-03
Merck USD 4.08B 493M 2024-12
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 7.55B 118M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Teva Pharmaceutical Industries USD 2.2B 168M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
United Therapeutics 6M 357.9M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Regeneron Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.